Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviour.
Ma
W
W
Kantarjian
H
H
Verstovsek
S
S
Jilani
I
I
Gorre
M
M
Giles
F
F
Cortes
J
J
O'Brien
S
S
Keating
M
M
Albitar
M
M
D005838:Genotype; D006801:Humans; D053614:Janus Kinase 2; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000401:mortality; D017354:Point Mutation; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D015996:Survival Rate
D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2